These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14593960)

  • 21. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
    Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
    Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of oxalate excretion in spot urines of healthy children by ion chromatography.
    von Schnakenburg C; Byrd DJ; Latta K; Reusz GS; Graf D; Brodehl J
    Eur J Clin Chem Clin Biochem; 1994 Jan; 32(1):27-9. PubMed ID: 8167190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary oxalate excretion in urolithiasis and nephrocalcinosis.
    Neuhaus TJ; Belzer T; Blau N; Hoppe B; Sidhu H; Leumann E
    Arch Dis Child; 2000 Apr; 82(4):322-6. PubMed ID: 10735843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.
    Sikora P; von Unruh GE; Beck B; Feldkötter M; Zajaczkowska M; Hesse A; Hoppe B
    Kidney Int; 2008 May; 73(10):1181-6. PubMed ID: 18337715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Hyperoxaluria in Urinary Stone Formers: Chronological and Geographical Trends and a Literature Review.
    Spradling K; Vernez SL; Khoyliar C; Morgan JB; Okhunov Z; Preminger GM; Lipkin ME; Landman J; Youssef RF
    J Endourol; 2016 Apr; 30(4):469-75. PubMed ID: 26738689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease.
    Hylander E; Jarnum S; Frandsen I
    Scand J Gastroenterol; 1979; 14(4):475-9. PubMed ID: 482860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis.
    Balla AA; Salah AM; Abdalmotaal E; Hoppe B; Bongartz D; Kessler T; Hesse A
    World J Urol; 1998; 16(6):413-6. PubMed ID: 9870291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.
    Sikora P; Beck B; Zajaczkowska M; Hoppe B
    Urol Res; 2009 Apr; 37(2):101-5. PubMed ID: 19183975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria.
    Dahiya T; Pundir CS
    Indian J Med Res; 2013 Jan; 137(1):136-41. PubMed ID: 23481063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
    Robertson WG; Hughes H
    Scanning Microsc; 1993 Mar; 7(1):391-401; discussion 401-2. PubMed ID: 8316808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.
    Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL
    Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments.
    Gupta M; Gallante B; Bamberger JN; Khusid JA; Parkhomenko E; Chandhoke R; Capodice J; Atallah W
    J Endourol; 2021 Dec; 35(12):1844-1851. PubMed ID: 34254834
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic etiology of urinary calculi in children].
    Gołabek B
    Probl Med Wieku Rozwoj; 1982; 11():65-81. PubMed ID: 7178091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.